167 related articles for article (PubMed ID: 34098051)
21. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.
Belletti D; Tosi G; Forni F; Lagreca I; Barozzi P; Pederzoli F; Vandelli MA; Riva G; Luppi M; Ruozi B
Eur J Pharm Biopharm; 2016 Feb; 99():7-17. PubMed ID: 26625717
[TBL] [Abstract][Full Text] [Related]
22. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
23. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes.
Muñoz-Ubeda M; Rodríguez-Pulido A; Nogales A; Martín-Molina A; Aicart E; Junquera E
Biomacromolecules; 2010 Dec; 11(12):3332-40. PubMed ID: 21058732
[TBL] [Abstract][Full Text] [Related]
24. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
25. Effect of pre‑freezing and saccharide types in freeze‑drying of siRNA lipoplexes on gene‑silencing effects in the cells by reverse transfection.
Tang M; Hu S; Hattori Y
Mol Med Rep; 2020 Oct; 22(4):3233-3244. PubMed ID: 32945442
[TBL] [Abstract][Full Text] [Related]
26. Targeted lipoplexes for siRNA delivery.
Cardoso A; Trabulo S; Moreira JN; Düzgüneş N; de Lima MC
Methods Enzymol; 2009; 465():267-87. PubMed ID: 19913172
[TBL] [Abstract][Full Text] [Related]
27. Functional Peptide-Modified Liposomes for siRNA Delivery to Rat Retinal Pigment Epithelium Cells: Effect of Peptide Sequences.
Nishida S; Takashima Y; Endo K; Ishihara H
Biol Pharm Bull; 2023; 46(10):1468-1478. PubMed ID: 37779049
[TBL] [Abstract][Full Text] [Related]
28. Aspects of nonviral gene therapy: correlation of molecular parameters with lipoplex structure and transfection efficacy in pyridinium-based cationic lipids.
Parvizi P; Jubeli E; Raju L; Khalique NA; Almeer A; Allam H; Manaa MA; Larsen H; Nicholson D; Pungente MD; Fyles TM
Int J Pharm; 2014 Jan; 461(1-2):145-56. PubMed ID: 24296044
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers.
Vaidya S; Mohod A; Eedara AC; Andugulapati SB; Pabbaraja S
ChemMedChem; 2023 Aug; 18(16):e202300097. PubMed ID: 37306531
[TBL] [Abstract][Full Text] [Related]
30. Atomic force microscopy imaging of DNA-cationic liposome complexes optimised for gene transfection into neuronal cells.
Wangerek LA; Dahl HH; Senden TJ; Carlin JB; Jans DA; Dunstan DE; Ioannou PA; Williamson R; Forrest SM
J Gene Med; 2001; 3(1):72-81. PubMed ID: 11269338
[TBL] [Abstract][Full Text] [Related]
31. Agitation during lipoplex formation harmonizes the interaction of siRNA to cationic liposomes.
Barichello JM; Kizuki S; Tagami T; Soares LA; Ishida T; Kikuchi H; Kiwada H
Int J Pharm; 2012 Jul; 430(1-2):359-65. PubMed ID: 22525078
[TBL] [Abstract][Full Text] [Related]
32. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
33. Cationic Liposome- Multi-Walled Carbon Nanotubes Hybrids for Dual siPLK1 and Doxorubicin Delivery In Vitro.
Pereira S; Lee J; Rubio N; Hassan HA; Suffian IB; Wang JT; Klippstein R; Ballesteros B; Al-Jamal WT; Al-Jamal KT
Pharm Res; 2015 Oct; 32(10):3293-308. PubMed ID: 26085038
[TBL] [Abstract][Full Text] [Related]
34. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
35. Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice.
Hattori Y; Tamaki K; Sakasai S; Ozaki KI; Onishi H
Mol Med Rep; 2020 Nov; 22(5):4183-4196. PubMed ID: 33000194
[TBL] [Abstract][Full Text] [Related]
36. Transdermal Delivery of Small Interfering RNA with Elastic Cationic Liposomes in Mice.
Hattori Y; Date M; Arai S; Kawano K; Yonemochi E; Maitani Y
J Pharm (Cairo); 2013; 2013():149695. PubMed ID: 26555966
[TBL] [Abstract][Full Text] [Related]
37. Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo.
Guo X; Gagne L; Chen H; Szoka FC
J Liposome Res; 2014 Jun; 24(2):90-8. PubMed ID: 24188532
[TBL] [Abstract][Full Text] [Related]
38. Anti-
Habib S; Daniels A; Ariatti M; Singh M
F1000Res; 2020; 9():770. PubMed ID: 33391729
[No Abstract] [Full Text] [Related]
39. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
40. Fine tuning of mixed ionic and hydrogen bond interactions for plasmid delivery using lipoplexes.
Seguin J; Dhotel H; Kai-Luen R; Bessodes M; Mignet N
Eur J Pharm Biopharm; 2015 Feb; 90():63-9. PubMed ID: 25448076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
